238 related articles for article (PubMed ID: 17651391)
41. Bile affects the synthesis of exopolysaccharides by Bifidobacterium animalis.
Ruas-Madiedo P; Gueimonde M; Arigoni F; de los Reyes-Gavilán CG; Margolles A
Appl Environ Microbiol; 2009 Feb; 75(4):1204-7. PubMed ID: 19088310
[TBL] [Abstract][Full Text] [Related]
42. Degradation of 16S rRNA and attributes of viability of viable but nonculturable probiotic bacteria.
Lahtinen SJ; Ahokoski H; Reinikainen JP; Gueimonde M; Nurmi J; Ouwehand AC; Salminen SJ
Lett Appl Microbiol; 2008 Jun; 46(6):693-8. PubMed ID: 18444975
[TBL] [Abstract][Full Text] [Related]
43. Effect of
Aoki R; Tsuchida S; Arai Y; Ohno K; Nishijima T; Mawatari T; Mikami Y; Ushida K
Food Sci Nutr; 2016 Nov; 4(6):782-790. PubMed ID: 27826427
[No Abstract] [Full Text] [Related]
44. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
Carey CM; Kostrzynska M; Ojha S; Thompson S
J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
[TBL] [Abstract][Full Text] [Related]
45. Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium.
Meile L; Le Blay G; Thierry A
Int J Food Microbiol; 2008 Sep; 126(3):316-20. PubMed ID: 17889391
[TBL] [Abstract][Full Text] [Related]
46. Acquisition of bile salt resistance promotes antibiotic susceptibility changes in bifidobacterium.
Noriega L; de los Reyes-Gavilán CG; Margolles A
J Food Prot; 2005 Sep; 68(9):1916-9. PubMed ID: 16161694
[TBL] [Abstract][Full Text] [Related]
47. Safety and the probiotic potential of Bifidobacterium animalis CP-9.
Tsai HY; Wang YC; Liao CA; Su CY; Huang CH; Chiu MH; Yeh YT
J Food Sci; 2022 May; 87(5):2211-2228. PubMed ID: 35347713
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria.
Kurdi P; Kawanishi K; Mizutani K; Yokota A
J Bacteriol; 2006 Mar; 188(5):1979-86. PubMed ID: 16484210
[TBL] [Abstract][Full Text] [Related]
49. Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains.
Rada V; Splichal I; Rockova S; Grmanova M; Vlkova E
Biotechnol Lett; 2010 Mar; 32(3):451-5. PubMed ID: 19943182
[TBL] [Abstract][Full Text] [Related]
50. Bile-inducible efflux transporter from Bifidobacterium longum NCC2705, conferring bile resistance.
Gueimonde M; Garrigues C; van Sinderen D; de los Reyes-Gavilán CG; Margolles A
Appl Environ Microbiol; 2009 May; 75(10):3153-60. PubMed ID: 19304838
[TBL] [Abstract][Full Text] [Related]
51. Short communication: Modulation of fatty acid metabolism improves oxygen tolerance of Bifidobacterium animalis ssp. lactis Probio-M8.
Zhang W; Wang Y; Li K; Kwok LY; Liu W; Zhang H
J Dairy Sci; 2020 Oct; 103(10):8791-8795. PubMed ID: 32861486
[TBL] [Abstract][Full Text] [Related]
52. Preservation of functionality of Bifidobacterium animalis subsp. lactis INL1 after incorporation of freeze-dried cells into different food matrices.
Vinderola G; Zacarías MF; Bockelmann W; Neve H; Reinheimer J; Heller KJ
Food Microbiol; 2012 May; 30(1):274-80. PubMed ID: 22265312
[TBL] [Abstract][Full Text] [Related]
53. Development of a growth medium suitable for exopolysaccharide production and structural characterisation by Bifidobacterium animalis ssp. lactis AD011.
Alhudhud M; Humphreys P; Laws A
J Microbiol Methods; 2014 May; 100():93-8. PubMed ID: 24632517
[TBL] [Abstract][Full Text] [Related]
54. Bile resistance in Lactococcus lactis strains varies with cellular fatty acid composition: analysis by using different growth media.
Kimoto-Nira H; Kobayashi M; Nomura M; Sasaki K; Suzuki C
Int J Food Microbiol; 2009 May; 131(2-3):183-8. PubMed ID: 19339076
[TBL] [Abstract][Full Text] [Related]
55. Novel Insights into the Molecular Mechanisms Underlying Robustness and Stability in Probiotic Bifidobacteria.
Schöpping M; Goel A; Jensen K; Faria RA; Franzén CJ; Zeidan AA
Appl Environ Microbiol; 2023 Mar; 89(3):e0008223. PubMed ID: 36802222
[TBL] [Abstract][Full Text] [Related]
56. Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults.
Rochet V; Rigottier-Gois L; Ledaire A; Andrieux C; Sutren M; Rabot S; Mogenet A; Bresson JL; Cools S; Picard C; Goupil-Feuillerat N; Doré J
J Mol Microbiol Biotechnol; 2008; 14(1-3):128-36. PubMed ID: 17957120
[TBL] [Abstract][Full Text] [Related]
57. Integrated transcriptomic and proteomic analysis of the bile stress response in a centenarian-originated probiotic Bifidobacterium longum BBMN68.
An H; Douillard FP; Wang G; Zhai Z; Yang J; Song S; Cui J; Ren F; Luo Y; Zhang B; Hao Y
Mol Cell Proteomics; 2014 Oct; 13(10):2558-72. PubMed ID: 24965555
[TBL] [Abstract][Full Text] [Related]
58. Application of a microplate scale fluorochrome staining assay for the assessment of viability of probiotic preparations.
Alakomi HL; Mättö J; Virkajärvi I; Saarela M
J Microbiol Methods; 2005 Jul; 62(1):25-35. PubMed ID: 15823392
[TBL] [Abstract][Full Text] [Related]
59. Method for direct selection of potentially probiotic Bifidobacterium strains from human feces based on their acid-adaptation ability.
Collado MC; Sanz Y
J Microbiol Methods; 2006 Sep; 66(3):560-3. PubMed ID: 16522337
[TBL] [Abstract][Full Text] [Related]
60. Effect of heat-shock and bile salts on protein synthesis of Bifidobacterium longum revealed by [35S]methionine labelling and two-dimensional gel electrophoresis.
Savijoki K; Suokko A; Palva A; Valmu L; Kalkkinen N; Varmanen P
FEMS Microbiol Lett; 2005 Jul; 248(2):207-15. PubMed ID: 15990254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
